Your browser doesn't support javascript.
loading
Tyrosine phosphorylation of band 3 impairs the storage quality of suspended red blood cells in the Tibetan high-altitude polycythemia population.
Wu, Xiaodong; Liu, Zhijuan; Hao, Doudou; Zhao, Qin; Li, Wanjing; Xie, Maodi; Feng, Xia; Liao, Xia; Chen, Siyuan; Wang, Siyu; Zhou, Chaohua; Long, Wenchun; Zhong, Yajun; Li, Shen; Cao, Ye; Wang, Hong; Wang, Aiping; Xu, Yuehong; Huang, Min; Liu, Jiaxin; Zhong, Rui; Wu, Yunhong; He, Zeng.
  • Wu X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
  • Liu Z; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
  • Hao D; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Zhao Q; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Li W; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
  • Xie M; Laboratory of Mitochondria and Metabolism, Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China.
  • Feng X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
  • Liao X; Department of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
  • Chen S; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Wang S; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Zhou C; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Long W; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Zhong Y; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
  • Li S; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
  • Cao Y; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
  • Wang H; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
  • Wang A; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
  • Xu Y; Department of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
  • Huang M; Department of Blood Transfusion, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
  • Liu J; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. jxliu@ibt.pumc.edu.cn.
  • Zhong R; Center of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. zhongrui@ibt.pumc.edu.cn.
  • Wu Y; Department of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. wu_yunhong@163.com.
  • He Z; Department of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. henkally@163.com.
J Transl Med ; 21(1): 676, 2023 09 28.
Article en En | MEDLINE | ID: mdl-37770909
ABSTRACT
Due to environmental hypoxia on the Tibetan Plateau, local residents often exhibit a compensative increase in hemoglobin concentration to maintain the body's oxygen supply. However, increases in hemoglobin and hematocrit (Hct) pose a serious challenge to the quality of stored suspended red blood cells (SRBCs) prepared from the blood of high-hemoglobin populations, especially populations at high altitude with polycythemia in Tibet. To explore the difference in storage quality of SRBCs prepared from plateau residents with a high hemoglobin concentration, blood donors were recruited from Tibet (> 3600 m) and Chengdu (≈ 500 m) and divided into a high-altitude control (HAC) group, high-altitude polycythemia (HAPC) group and lowland control (LLC) group according to their hemoglobin concentration and altitude of residence. The extracellular acidification rate (ECAR), pyruvate kinase (PK) activity and band 3 tyrosine phosphorylation were analyzed on the day of blood collection. Then, whole-blood samples were processed into SRBCs, and storage quality parameters were analyzed aseptically on days 1, 14, 21 and 35 of storage. Overall, we found that tyrosine 21 phosphorylation activated glycolysis by releasing glycolytic enzymes from the cytosolic domain of band 3, thus increasing glucose consumption and lactate accumulation during storage, in the HAPC group. In addition, band 3 tyrosine phosphorylation impaired erythrocyte deformability, accompanied by the highest hemolysis rate in the HAPC group, during storage. We believe that these results will stimulate new ideas to further optimize current additive solutions for the high-hemoglobin population in Tibet and reveal new therapeutic targets for the treatment of HAPC populations.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policitemia / Mal de Altura Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Policitemia / Mal de Altura Límite: Humans País como asunto: Asia Idioma: En Año: 2023 Tipo del documento: Article